Flora Growth Corp. (FLGC)
- Previous Close
1.2700 - Open
1.3000 - Bid 1.2700 x 100
- Ask 1.3800 x 100
- Day's Range
1.3000 - 1.3800 - 52 Week Range
0.6300 - 2.9290 - Volume
40,299 - Avg. Volume
86,712 - Market Cap (intraday)
17.644M - Beta (5Y Monthly) 1.80
- PE Ratio (TTM)
-- - EPS (TTM)
-0.9000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.00
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
www.floragrowth.com97
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: FLGC
View MorePerformance Overview: FLGC
Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FLGC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FLGC
View MoreValuation Measures
Market Cap
16.98M
Enterprise Value
16.46M
Trailing P/E
--
Forward P/E
7.06
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.17
Price/Book (mrq)
2.32
Enterprise Value/Revenue
0.24
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-21.56%
Return on Assets (ttm)
-16.62%
Return on Equity (ttm)
-135.37%
Revenue (ttm)
69.01M
Net Income Avi to Common (ttm)
-13.48M
Diluted EPS (ttm)
-0.9000
Balance Sheet and Cash Flow
Total Cash (mrq)
6.13M
Total Debt/Equity (mrq)
67.86%
Levered Free Cash Flow (ttm)
1.4M